Vince Flynn

San Francisco – February 9, 2023 – Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Cooley advised VelosBio, a clinical-stage biopharmaceutical company, on its agreement to sell to Merck, through a subsidiary, for $2.75 billion. Cooley lawyers Barbara Borden, Ken Rollins and Rowook Park led the team advising VelosBio on the transaction, which is expected to close by the end of 2020.

Cooley advised Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, on its agreement to sell to Sanofi for approximately $2.5 billion. Partners Barbara Borden, Rama Padmanabhan and Ken Rollins led the Cooley team.

Cooley advised leading analytics platform Tableau on its agreement to sell to Salesforce in a $15.7 billion all-stock transaction. Lawyers Jamie Leigh, Ben Beerle, Jodie Bourdet and Ian Nussbaum led the Cooley team advising Tableau on the deal, which is expected to close early in Q4. read more

Cooley advised Ellie Mae, a cloud-based platform provider for the mortgage finance industry, on its agreement to sell to private equity firm Thoma Bravo for approximately $3.7 billion. The transaction is expected to close in Q2 or Q3.